• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There is a lack of information about how long-term exposure to these drugs can affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological conditions like hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication should evaluate the benefits of using it versus the risks to the baby. Doctors don't have the data needed to make unequivocal recommendations, but they can provide information regarding risks and benefits that help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications during their early pregnancy did not have a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers conducted a large population-based study of case-control to evaluate the incidence of major structural birth defects in babies born to mothers who had taken stimulants in early pregnancy, and those who did not. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to confirm that the classification was accurate and to reduce any bias.

The research conducted by the researchers was not without its limitations. Most important, they were not able to differentiate the effects of the medication from the underlying disorder. This makes it difficult for researchers to determine whether the small differences observed between the groups exposed were due to the use of medication or if they were caused by the presence of comorbidities. Additionally the researchers did not look at the long-term outcomes of offspring.

The study did reveal that infants whose mothers had taken ADHD medication during pregnancy were at a higher risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or had stopped their medications before or during pregnancy. The reason for this was central nervous system-related disorders and the higher risk of admission did not appear to be influenced by which stimulant medications were taken during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication used during pregnancy.

The researchers suggest that the risk of a small amount with the use of adhd medication pregnancy medications during early pregnancy could be offset by the greater benefits for both mother and child of continuing treatment for the woman's disorder. Physicians should discuss the issue with their patients and, when they are able, assist them in developing strategies to improve coping skills which can reduce the impact of her disorder on her daily functioning and relationships.

Medication Interactions

Many doctors are faced with the decision of whether to keep treatment or stop it during pregnancy as more women are diagnosed with ADHD. Often, these decisions are made in the absence of clear and authoritative evidence in either case, which means that doctors have to weigh their experience about their experiences, the experiences of other doctors, and what the research says on the topic, along with their own best judgment for each patient.

Particularly, the issue of possible risks to the baby can be a challenge. A lot of studies on this subject are based on observations instead of controlled research and their findings are often contradictory. Most studies focus on live births, which may underestimate the severity of teratogenic effects that can lead to abortions or terminations of pregnancy. The study that is discussed in this journal club addresses these issues by looking at data from both live and deceased births.

Conclusion: While some studies have found an association between ADHD medications and certain birth defects however, other studies haven't established a link. Most studies show that there is a neutral, or slightly negative, impact. In every case an in-depth analysis of the benefits and risks must be performed.

For many women with ADHD and ADD, the decision to stop taking medication is difficult, if not impossible. In a recent article in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping adhd medication ritalin medication during pregnancy can lead to increased depression, feelings of isolation, and family conflict for patients with ADHD. A decrease in medication could also affect the ability to drive safely and perform work-related tasks, which are essential aspects of daily life for those suffering from ADHD.

She suggests that women who aren't sure whether to continue taking the medication or stop due to pregnancy, educate their family members, coworkers, and their friends about the condition, the effects on daily functioning, and the benefits of continuing the current treatment regimen. It can also help women feel confident about her decision. Some medications can a general physician prescribe adhd medication (Learn Additional) pass through the placenta. If a woman decides to stop taking her ADHD medication while breastfeeding, it is crucial to be aware that the drug could be transferred to the infant.

Birth Defects Risk

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns about what impact the drugs might have on foetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. Researchers used two massive data sets to examine more than 4.3 million pregnancies and determine if the use of stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, first-trimester ADHD medication use was associated with slightly higher risk of certain heart defects, such as ventriculoseptal defect.

The researchers of the study could not discover any connection between the use of early medications and congenital anomalies like facial deformities, or club feet. The results are in line with previous studies showing a small but significant increase in the risk of cardiac malformations among women who began taking ADHD medications prior to the birth of their child. The risk increased in the latter half of pregnancy when a large number of women began to stop taking their medication.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean birth, have a low Apgar after delivery, and have a baby that needed breathing assistance after birth. However the authors of the study were not able to eliminate selection bias by limiting the study to women who did not have any other medical issues that could have contributed to the findings.

Researchers hope that their study will provide doctors with information when they see pregnant women. They suggest that although discussing the benefits and risks is important however, the decision to stop or keep medication should be based on the woman's needs and the severity of her ADHD symptoms.

The authors warn that, although stopping the medication is a possibility to consider, it is not recommended due to the high rate depression and mental health issues in women who are expecting or have recently given birth. Additionally, research suggests that women who stop taking their medications will have a tough adjustment to life without them after the baby is born.

Nursing

It can be a challenge becoming a mother. Women who suffer from ADHD who have to deal with their symptoms while attending doctor appointments as well as making preparations for the arrival of their child and adapting to new routines in the home can experience severe challenges. Many women decide to continue taking their adhd medication cost uk medication during pregnancy.

The risk to a breastfeeding infant is minimal because the majority of stimulant medication passes through breast milk at low levels. However, the rate of medication exposure to the newborn can vary depending on dosage, how often it is administered, and the time of day the medication is administered. In addition, various medications enter the baby’s system through the gastrointestinal tract, or through breast milk. The effect on a newborn's health is not completely understood.

Some physicians may discontinue stimulant medication during a woman's pregnancy due to the lack of research. This is a difficult decision for the patient, who must weigh the benefit of continuing her medication with the potential dangers to the foetus. As long as more information is available, GPs can inquire about pregnant patients whether they have any history of ADHD or if they intend to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue taking their ADHD medication in a safe manner during pregnancy and breast-feeding. In response, an increasing number of patients are choosing to do so. They have found after consulting with their physicians that the benefits of keeping their current medication outweigh possible risks.

Women with ADHD who are planning to nurse should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also needed to help pregnant women suffering from ADHD understand the symptoms and the underlying disorder. They should also learn about treatment options and build coping mechanisms. This should include an approach that is multidisciplinary, including the GP, obstetricians and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother as well as the child, as well as monitoring for signs of deterioration, and, if needed modifications to the medication regimen.